The FDA has granted accelerated approval to Regeneron Pharmaceuticals’ Otarmeni™ (lunsotogene parvec-cwha) as the first gene ...

Teradata reports that 88% of AI pilots fail to reach production due to fragmented data architectures, highlighting the need ...

Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...

The Punjab Disaster Management Authority has warned of above-normal temperatures and increased rainfall across parts of ...

When my one-month-old daughter was diagnosed with biliary atresia — a rare disease that for most of human history was ...

The democratic exercise in India is often described as a festival, a vibrant spectacle of participation that defines the nation’s spirit.

Over the past few decades, neuroscientists and medical researchers worldwide have been trying to leverage available health ...

Essent Group’s P&C reinsurance platform, including the Lloyd’s program and quota share transaction, is positioned as a ...

A new backlash against generative AI is taking shape, and it is less about the technology than who owns your image, voice and ...

Your security controls aren't failing, they're missing where most of today's work actually happens. Keep Aware shows how ...